A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma

Published:2015-07-06 Issue:20 Volume:121 Page:3622-3630
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Griffin Patrick T.¹,Ho Viet Q.²,Fulp William³,Nishihori Taiga⁴,Shain Kenneth H.¹,Alsina Melissa⁴,Baz Rachid C.¹

Affiliation:

1. Department of Malignant Hematology; H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

2. Department of Pharmacy; H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

3. Department of Biostatistics; H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

4. Department of Blood and Marrow Transplantation; H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29533/fullpdf

Reference25 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood.,2008

2. Autologous transplantation and maintenance therapy in multiple myeloma;Palumbo;N Engl J Med.,2014

3. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results;Gay;Blood.,2013

4. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma;Benboubker;N Engl J Med.,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma;Annals of Hematology;2024-09-04

2. Retrospective study on pomalidomide‐PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma;European Journal of Haematology;2024-06-19

3. Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable;Clinical Lymphoma Myeloma and Leukemia;2024-05

4. Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-12

5. Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China;Annals of Medicine;2023-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3